Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis

被引:0
作者
Francois Chasset
Camille Francès
机构
[1] Hôpital Tenon,Université Pierre et Marie Curie
来源
Clinical Reviews in Allergy & Immunology | 2017年 / 53卷
关键词
Takayasu arteritis; Giant-cell arteritis; Polyarteritis nodosa; Kawasaki disease;
D O I
暂无
中图分类号
学科分类号
摘要
Dermatologic manifestations are observed in almost all systemic vasculitides, even in large-and medium-vessel vasculitides, although such vessels are not found in the skin. Cutaneous manifestations may be related to a direct skin localization of the systemic vasculitis or a non-specific process associated with the vasculitis. According to the 2012 International Chapel Hill consensus, the two major variants of large-vessel vasculitides are Takayasu arteritis and giant-cell arteritis. In Europe and North America, acute inflammatory nodules or erythema nodosum-like lesions are the most commonly observed skin lesions with Takayasu arteritis. Medium-sized arteriole vasculitis of the dermis or subcutis but also septal or lobular panniculitis may be found during pathological examination. In Japan, widespread pyoderma gangrenosum-like lesions are more frequent. Cutaneous manifestations of giant-cell arteritis are rare; they are ischemic, linked to arterial occlusions, or non-ischemic, with various mechanisms. The two major medium-vessel vasculitides are Kawasaki disease and polyarteritis nodosa. Kawasaki disease is characterized by a mucocutaneous lymph node syndrome without skin vasculitis. Two subsets of polyarteritis nodosa with different skin manifestations are described, without transition from one to the other. In the systemic subset, the most frequent skin lesions are in the order of frequency purpura, livedo, and nodules. Cutaneous polyarteritis nodosa mainly features nodules, livedo racemosa, and ulcerations. Genetic screening and measurement of plasma levels of adenosine deaminase 2 should be considered for patients with uncommon systemic polyarteritis nodosa or early-onset cutaneous polyarteritis nodosa.
引用
收藏
页码:452 / 468
页数:16
相关论文
共 283 条
  • [1] Jennette JC(2013)2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Arthritis Rheum 65 1-11
  • [2] Falk RJ(2009)Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine (Baltimore) 88 221-226
  • [3] Bacon PA(2000)Takayasu’s arteritis Lancet Lond Engl 356 1023-1025
  • [4] Maksimowicz-McKinnon K(2017)Prevalence, incidence, and disease characteristics of Takayasu arteritis by ethnic background: data from a large, population-based cohort resident in southern Norway Arthritis Care Res 69 278-285
  • [5] Clark TM(2016)Revisited HLA and non-HLA genetics of Takayasu arteritis—where are we? J Hum Genet 61 27-32
  • [6] Hoffman GS(2017)Absence of mycobacterial DNA in peripheral blood and artery specimens in patients with Takayasu arteritis Clin Rheumatol 36 205-208
  • [7] Numano F(1985)Takayasu’s arteritis and its therapy Ann Intern Med 103 121-126
  • [8] Okawara M(2013)Cutaneous manifestations and comorbidities in 60 cases of Takayasu arteritis J Rheumatol 40 734-738
  • [9] Inomata H(1987)Cutaneous manifestations of Takayasu’s arteritis. A clinicopathologic correlation J Am Acad Dermatol 17 998-1005
  • [10] Kobayashi Y(1986)Cutaneous extravascular necrotizing granuloma in a patient with Takayasu’s aortitis Arch Dermatol 122 201-204